logologo

Trending

Alerts

Newsletter

Search

Trending

Alerts

Newsletter

Log In

Sign Up

Uptrends.ai brand logo by Babbl
Uptrends TwitterUptrends InstagramUptrends LinkedinCommunity Discord
product
PricingHow it worksReviewsFeatured in
resources
BlogFAQsQuick startCommunityChange log
company
Explore CareersContact SupportContact SalesBecome a SponsorBecome an Affiliate ✨
© 2024 Babbl Labs, Inc.
Terms & conditions
Privacy policy
Company Logo

Apellis Pharmaceuticals

APLS

Biotech

Health Care

Pharma

Country

US

Industry

Health Care

Market Cap

Large Cap

Num. Employees

767

IPO Date

Nov 9, 2017

APLS

Country

US

Industry

Health Care

Biotech

Health Care

+1


Apellis Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel therapeutic compounds to treat diseases with high unmet needs. The company is headquartered in Waltham, Massachusetts and currently employs 767 full-time employees. The company went IPO on 2017-11-09. The firm is focused on the discovery, development and commercialization of therapeutic compounds to treat diseases with high unmet needs through the inhibition of the complement system. Its SYFOVRE (pegcetacoplan injection) is the Company’s approved treatment for geographic atrophy secondary to age-related macular degeneration (GA). The Company’s EMPAVELI (pegcetacoplan) is the treatment of paroxysmal nocturnal hemoglobinuria (PNH). Its Aspaveli (pegcetacoplan) is the treatment of adults with PNH who are anemic after treatment with a C5 inhibitor for at least three months. Systemic pegcetacoplan has an approval for the treatment of PNH in Saudi Arabia, Australia, and the United Kingdom. Systemic pegcetacoplan markets under the trade name EMPAVELI in the United States, Saudi Arabia and Australia and Aspaveli in the European Union and United Kingdom.

Mentions

Mentions

Mentions of this stock across all news source scraped in the past 30 days

Recent Mentions

Recent articles, blogs, and social posts pertaining to this stock

No data available

News Events

News Events

Recent alerts triggered for APLS from the last 30 days


•


•


•


•


•


•


•


•

Recent Mentions

Recent Mentions

Recent articles, blogs, and social posts pertaining to this stock

APLS

See sentiment for APLS and 5000+ other stocks

Lorem Ipsum

•

Jan 1

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.

Lorem • Ipsum

Lorem Ipsum

•

Jan 1

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.

Lorem • Ipsum

Lorem Ipsum

•

Jan 1

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.

Lorem • Ipsum

Lorem Ipsum

•

Jan 1

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.

Lorem • Ipsum

Lorem Ipsum

•

Jan 1

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.

Lorem • Ipsum

Lorem Ipsum

•

Jan 1

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.

Lorem • Ipsum

Related Stocks

Related Stocks

Stocks being mentioned with APLS

PFE

94% Match

Pfizer

$25.38

+0.12%

Very Bearish

VRTX

94% Match

Vertex Pharmaceuticals

$459.62

+0.26%

Very Bearish

REGN

94% Match

Regeneron Pharmaceuticals

$547.36

-0.07%

Very Bearish

BMRN

94% Match

BioMarin Pharmaceutical

$57.50

+0.07%

Very Bearish

UTHR

94% Match

United Therapeutics

$294.49

-0.40%

Very Bearish

RPRX

89% Match

Royalty Pharma

$36.37

+0.65%

Very Bearish

GSK

89% Match

GlaxoSmithKline

$38.18

-0.50%

Very Bearish